IIA
AVDL

IPG Investment Advisors’s Avadel Pharmaceuticals AVDL Stock Holding History

IPG Investment Advisors’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-10,800
Closed -$72.1K – 194
2020
Q4 		$72.1K Buy
+10,800
New +$67.5K 0.02% 164

Other funds holding AVDL

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Asymmetry Capital Management San Francisco, California $188M AUM 44.72% 1-Year Est. Return

IPG Investment Advisors's AVDL Position: Q1 2021 in Review

IPG Investment Advisors sold out of Avadel Pharmaceuticals (AVDL) in Q1 2021, closing a stake of 10,800 shares — an estimated $72.1K sold.

IPG Investment Advisors first reported a position in AVDL in Q4 2020 and held it in 1 quarter. The position peaked at $72.1K in Q4 2020. 76 funds tracked by Wall St. Rank hold AVDL as of Q1 2021.

  • IPG Investment Advisors reported no remaining Avadel Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • IPG Investment Advisors sold 10,800 Avadel Pharmaceuticals shares in Q1 2021, an estimated $72.1K.
  • IPG Investment Advisors first reported a position in Avadel Pharmaceuticals in Q4 2020 and held it in 1 quarter.
  • IPG Investment Advisors's Avadel Pharmaceuticals position peaked at $72.1K in Q4 2020.
  • 76 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2021.

Based on IPG Investment Advisors's 13F filing for Q1 2021, filed 12 May 2021.